ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2228

Involvement of Receptor Tyrosine Kinase a  Signaling in Rhumatoid Arthritis Using Trka/C Knock-in Mice: A Multimodal Approach

Lauriane Delay1, Julie Barbier1, Ludivine Boudieu1, Denis Ardid1, Arnaud Briat2, Philippe Auzeloux2, Elisabeth Moit-Noirault2, Aziz Moqrich3 and Fabien Marchand1, 1Inserm U1107 NeuroDol, Université Clermont Auvergne, Clermont-Ferrand, France, 24UMR 1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, France, 3UMR 6216 CNRS-Université de la Méditerranée, Institut de Biologie du Développement de Marseille Luminy, Marseille, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Bone, neurology and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Pain – Basic and Clinical Aspects Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid Arthritis (RA) is an autoimmune disease very commonly associated with chronic pain which is often resistant to currents analgesics. Targeting Nerve Growth Factor (NGF), a neurotrophic factor, is already considered a very promising treatment of RA. However, it could lead to serious adverse effects. Our aim is to better understand the involvement of the specific intracellular signaling pathways activated by NGF through the tyrosine kinase type A (TrkA) receptor, in the pathophysiology of RA especially those involved in associated chronic pain.

Methods:

We performed a multimodal study in TrkA/C knock-in mice expressing a chimeric receptor formed by the native extracellular part of TrkA and the functional transmembrane and intracellular part of the tyrosine kinase type C receptor (TrkC) which binds neurotrophin 3 (NT3). We investigated nociceptive behavior such as mechanical allodynia and thermal hyperalgesia using von Frey and paw immersion test in CFA induced-arthritis model. In vivo cartilage and bone remodeling were assessed by scintigraphic imaging using 99mTc-NTP 15-5 and 99mTc-HMDP radiotracers, respectively. CD68 positive cell infiltration and CGRP positive nerve fibers sprouting were assessed in the joint as well as TrkA and ASIC3 expression in DRG cells bodies using an immunohistochemical approach. We are currently investigating the intracellular pathway potentially involved at the DRG level.

Results: Our results showed a specific lack of mechanical allodynia development while thermal hyperalgesia was unaffected in TrkA/C monoarthritic mice compared to WT littermates. This change in pain behavior was associated with a specific decrease of 99mTc-HMDP in TrkA/C monoarthritic mice, suggesting a unique change in bone remodeling. Indeed, cartilage remodeling was similar between both genotypes. We also observed a decrease of CD68-positive cell infiltration as well as CGRP expression in the inflamed joint in TrkA/C mice compared to WT mice while the expression of TrkA and ASIC3 in the DRGs was unaffected between both genotypes following monoarthritis.

Conclusion:

The present study demonstrates a specific involvement of NGF/TrkA signaling in pain, especially mechanical hypersensitivity and also bone remodeling in inflammatory arthritis. We are now investigated the specific intracellular pathway involved.


Disclosure: L. Delay, None; J. Barbier, None; L. Boudieu, None; D. Ardid, None; A. Briat, None; P. Auzeloux, None; E. Moit-Noirault, None; A. Moqrich, None; F. Marchand, None.

To cite this abstract in AMA style:

Delay L, Barbier J, Boudieu L, Ardid D, Briat A, Auzeloux P, Moit-Noirault E, Moqrich A, Marchand F. Involvement of Receptor Tyrosine Kinase a  Signaling in Rhumatoid Arthritis Using Trka/C Knock-in Mice: A Multimodal Approach [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/involvement-of-receptor-tyrosine-kinase-a-signaling-in-rhumatoid-arthritis-using-trkac-knock-in-mice-a-multimodal-approach/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-receptor-tyrosine-kinase-a-signaling-in-rhumatoid-arthritis-using-trkac-knock-in-mice-a-multimodal-approach/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology